Life sciences · Preprint
arXiv · October 29, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Preprint.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Foundation models trained on longitudinal electronic health records (EHRs) can predict clinical diagnoses years in the future, making them a potential tool for disease screening. We developed TRACER (Temporal Risk Assessment with Clinical EHR Representations), a decoder-based foundation model pretrained on data from over 4.5 million patients from four health systems, and evaluated it on 16 incident diseases at 1-, 2-, and 5-year horizons in more than 2 million patients from two health systems excluded from model development. In contrast to typical evaluations that focus on global metrics (e.g., AUROC), we measured performance at the low false-positive rates that are realistic for screening. We found that TRACER retained its discrimination in external health systems, and at 95% specificity, the patients it flagged were up to eight times more likely to be diagnosed within a year than unselected patients. Evaluating at this operating point also revealed what global metrics alone did not: detection and false-alert burden varied across diseases and health systems, even when discrimination appeared stable. Our results illustrate the potential of foundation models for screening and underscore the need for evaluation in health systems excluded from development to assess disease detection and false-alert burden at levels appropriate for intended clinical use.}